Geoffrey T. Yarranton
Overview
Geoffrey T. Yarranton received an average of $477K in total compensation, including $281K in salary, at KaloBios Pharmaceuticals between 2011 and 2013.
Source: SEC filings on April 29, 2014 and October 29, 2012.
Related executives
We found nine more executives who work or worked at KaloBios Pharmaceuticals.
Cameron Durrant
KaloBios Pharmaceuticals
Chief Executive Officer
Adrian Kilcoyne
KaloBios Pharmaceuticals
Chief Medical Officer
Timothy Morris
KaloBios Pharmaceuticals
Chief Operating and Financial Officer
David Tousley
KaloBios Pharmaceuticals
Secretary
Dale Chappell
KaloBios Pharmaceuticals
Chief Scientific Officer
David Pritchard
KaloBios Pharmaceuticals
Chief Executive Officer
Néstor Molfino
KaloBios Pharmaceuticals
Chief Medical Officer
Jeffrey Cooper
KaloBios Pharmaceuticals